European Journal of Internal Medicine
Volume 20, Issue 5 , Pages 474-477 , September 2009

Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (Highly Active Antiretroviral Therapy)

Received 8 April 2008 ,Revised 17 December 2008 ,Accepted 4 January 2009.

References 

  1. Durack DT, Street AC. In:  Remington JS,  Swartz MN editor. Fever of unknown origin—reexaminated and redefined. Curr Clin Top Infect Dis. vol. 11:Boston; 1991;p. 35–51
  2. Bissuel F, Leport C, Perronne C, Longuet P, Vildé JL. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med. 1994;236:529–535
  3. Barba R, Gómez-Rodrigo J, Marco J, Rondón P, Eroles G, López Varas M, et al. Fever on unknown origin in patients with HIV. An Med Interna (Madrid). 2001;18:181–186
  4. Riera M, Altés R, Homar F, Picco G, Salas A, Leyes M, et al. Fever of unknown origin in patients with HIV infection. Enferm Infecc Microbiol Clin. 1996;14:581–585
  5. Septowitz KA, Telzak EE, Carrow M, Armstrong D. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med. 1993;153:1909–1912
  6. Alonso M, Gómez JL, Santolaria F, Rodríguez F, Esaardan H, Rodríguez E, et al. The efficacy of antirretroviral treatment in patients with human immunodeficiency virus infection. A study of 807 patients. Med Clin (Barc). 2000;115:481–486
  7. Palella FJ, Delavey KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:860–865
  8. Mayo J, Collazos J, Martínez E. Fever of unknown origin in the setting of HIV Infection: Guidelines for a Rational Approach AIDS Patients Care and STDs 1998; 12: 373–378.
  9. Miralles P, Moreno S, Pérez-Tascón M, Cosín J, Díaz MD, Bouza E, et al. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995;20:872–875
  10. Kreijn E, Vanderbroucke JP, Van der Meer JW. Fever of unknown origin. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore). 1997;76:392–400
  11. Mathurin SA, Lupo S, Alonso HO. Fever of unknown origin in patients infected with the human immunodeficiency virus. Medicina (Buenos Aires). 2000;60:623–630
  12. Mayo J, Collazos J, Martínez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scan J Infect Dis. 1997;29:327–336
  13. Lozano F, Torre-Cisneros J, Santos J, León E, Domínguez A, Montesdeoca M, et al. Impact of highly active antirretroviral therapy on fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:137–139
  14. Barbado FJ, Peña JM. Fever of unknown origin in HIV infection. New facts of an old problem. Med Clin (Barc). 1995;105:615–616
  15. Genné D, Chave JP, Glauser MP. Fever of unknown origin in a cohort of HIV-positive patients. Schweiz med Wschr. 1992;122:1797–1802
  16. Armstrong WS, Katz PH, Kazanjian JT. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999;28:341–345
  17. Alvar J, Canavate C, Gutierrez-Solar B, Jiménez M, Laguna F, López VR, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997;10:298–319
  18. Pintado V, Martín-Rabadán P, Rivera ML, Moreno S, Bouza E. Visceral leishmaniasis in human immunodeficiency virus–infected and non HIV–infected patients. Medicine (Baltimore). 2001;80:54–73
  19. Castilla J, De la Fuente L. Trends in the number of human immunodeficiency virus infected persons and AIDS cases in Spain: 1980–1998. Med Clin (Barc). 2000;115:85–89
  20. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS defining illnesses in the era of antirretroviral therapy. AIDS. 1997;11:1731–1738
  21. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000;14:1985–1991
  22. Costa R. La Infección por Mycobacterium Avium–Intracellulare Asociada al SIDA en un Hospital del Area Sur de Madrid. Estudio Clínico y Epidemiológico. Tesis Doctoral. Universidad Complutense de Madrid. 2002.
  23. Villanueva JL, Alarcón A, Bernabeu-Wittel M, Cordero E, Prados D, Regordán C, et al. Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2000;19:798–801
  24. Fernández-Cotarelo MJ, Abellán-Martínez J, Guerra-Vales JM, Martínez P, Rodrigo M, Salto E. Effect of highly active antiretroviral therapy on the incidence and clinical manifestation of visceral leishmaniasis in human immunodeficiency virus infected patients. Clin Infect Dis. 2003;37:973–977

PII: S0953-6205(09)00003-X

doi: 10.1016/j.ejim.2009.01.004

European Journal of Internal Medicine
Volume 20, Issue 5 , Pages 474-477 , September 2009

Article Tools

* Image Usage & Resolution